At the time of writing, Exelixis Inc [EXEL] stock is trading at $45.72, up 5.42%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EXEL shares have gain 9.51% over the last week, with a monthly amount glided 6.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on June 24, 2025, when Stephens upgraded its rating to a Overweight but kept the price target unchanged to $60 for it. Previously, Wells Fargo downgraded its rating to Equal Weight on February 24, 2025, and kept the price target unchanged to $36. On January 27, 2025, upgrade upgraded it’s rating to Overweight and revised its price target to $40 on the stock. Oppenheimer downgraded its rating to a Perform. BMO Capital Markets downgraded its rating to a Market Perform and raised its price target to $40 on December 20, 2024. BofA Securities downgraded its rating to Neutral for this stock on December 17, 2024, and upped its price target to $39. In a note dated October 16, 2024, RBC Capital Mkts reiterated an Outperform rating on this stock and boosted its target price from $30 to $34.
For the past year, the stock price of Exelixis Inc fluctuated between $21.82 and $49.62. Currently, Wall Street analysts expect the stock to reach $42.6 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $45.72 at the most recent close of the market. An investor can expect a potential drop of -6.82% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
According to Exelixis Inc [NASDAQ:EXEL], the company’s sales were 2.30B for trailing twelve months, which represents an 30.62% jump. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.36%, and Net Profit Margin reading is 0.28%. To continue investigating profitability, this company’s Return on Assets is posted at 0.23, Equity is 0.29 and Total Capital is 0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.40 points at the first support level, and at 43.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.59, and for the 2nd resistance point, it is at 47.45.
Ratios To Look Out For
It is important to note that Exelixis Inc [NASDAQ:EXEL] has a current ratio of 3.50. In addition, the Quick Ratio stands at 3.44 and the Cash Ratio stands at 0.46. Considering the valuation of this stock, the price to sales ratio is 5.42, the price to book ratio is 5.90 and price to earnings (TTM) ratio is 20.74.
Transactions by insiders
Recent insider trading involved Eckhardt Sue Gail, Director, that happened on Jun 02 ’25 when 18838.0 shares were sold. Director, WYSZOMIERSKI JACK L completed a deal on Jun 03 ’25 to sell 7535.0 shares. Meanwhile, Director JACK L WYSZOMIERSKI bought 7535.0 shares on Jun 03 ’25.
